Literature DB >> 24734938

Multimodality imaging features, metastatic pattern and clinical outcome in adult extraskeletal Ewing sarcoma: experience in 26 patients.

B S Somarouthu1, A B Shinagare, M H Rosenthal, H Tirumani, J L Hornick, N H Ramaiya, S H Tirumani.   

Abstract

OBJECTIVE: To describe the multimodality imaging features, metastatic pattern and clinical outcome in adult extraskeletal Ewing sarcoma (EES).
METHODS: In this institutional review board-approved, health insurance portability and accountability act-compliant retrospective study, we included 26 patients (17 females and 9 males; mean age, 36 years; range, 18-85 years) with pathologically confirmed EES seen at our institute between 1999 and 2011, who had imaging of primary tumour. Imaging of primary tumour in all 26 patients and follow-up imaging in 23 was reviewed by two radiologists in consensus. Clinical data were extracted from electronic medical records.
RESULTS: The most common primary sites were the torso (n = 13), extremities (n = 10) and head and neck (HN) region (n = 3). The mean tumour size was 9 cm (range, 3-22 cm); tumours of the torso were larger than those of other areas (p > 0.05). Compared with the skeletal muscle, tumours were isodense on CT (21/21), hypointense (n = 5) to isointense (n = 14) on T1 weighted image, hyperintense on T2 weighted image (19/19) and were fluorine-18 fludeoxyglucose ((18)F-FDG)-avid [10/10; mean maximum standardized uptake value of 7 (range, 3-11)]. Necrosis (15/26), haemorrhage (5/26) and adjacent organ invasion (14/26) were present without calcification. Median follow-up was 16 months. 5 patients had local recurrence (torso, 3; extremity, 1; and HN, 1). Metastases developed in 11 patients (torso, 7; extremities, 3; and HN, 1; p > 0.05); 8 at presentation, most commonly to lung (9/11), peritoneum (4/11), muscles (4/11) and lymph nodes (4/11). Nine patients (torso, 7; extremity, 1; and HN, 1) died (10 months median survival) (p > 0.05).
CONCLUSION: Adult EESs are large tumours, which frequently invade adjacent organs and metastasize to the lung. EESs of the torso are larger, have more frequent metastases and poorer outcomes. ADVANCES IN KNOWLEDGE: Adult EESs of the torso have poor outcomes compared with other EESs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24734938      PMCID: PMC4075565          DOI: 10.1259/bjr.20140123

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  21 in total

Review 1.  Diagnostic accuracy of ¹⁸F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis.

Authors:  Giorgio Treglia; Marco Salsano; Antonella Stefanelli; Maria Vittoria Mattoli; Alessandro Giordano; Lorenzo Bonomo
Journal:  Skeletal Radiol       Date:  2011-11-10       Impact factor: 2.199

Review 2.  Imaging features of peripheral primitive neuroectodermal tumours.

Authors:  S Hari; T P Jain; S Thulkar; S Bakhshi
Journal:  Br J Radiol       Date:  2008-09-01       Impact factor: 3.039

3.  Extraskeletal Ewing sarcomas in late adolescence and adults: a study of 37 patients.

Authors:  Hai-Tao Tao; Yi Hu; Jin-Liang Wang; Yao Cheng; Xin Zhang; Huan Wang; Su-Jie Zhang
Journal:  Asian Pac J Cancer Prev       Date:  2013

4.  Adults with Ewing's sarcoma/primitive neuroectodermal tumor: adverse effect of older age and primary extraosseous disease on outcome.

Authors:  E H Baldini; G D Demetri; C D Fletcher; J Foran; K C Marcus; S Singer
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

5.  Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.

Authors:  Deniz Tural; Nil Molinas Mandel; Sergulen Dervisoglu; Fazilet Oner Dincbas; Sedat Koca; Didem Colpan Oksuz; Fatih Kantarci; Hande Turna; Fatih Selcukbiricik; Murat Hiz
Journal:  Jpn J Clin Oncol       Date:  2012-03-12       Impact factor: 3.019

6.  Preliminary efficacy of the anti-insulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcoma.

Authors:  Heribert Juergens; Najat C Daw; Birgit Geoerger; Stefano Ferrari; Milena Villarroel; Isabelle Aerts; Jeremy Whelan; Uta Dirksen; Mary L Hixon; Donghua Yin; Tao Wang; Stephanie Green; Luisa Paccagnella; Antonio Gualberto
Journal:  J Clin Oncol       Date:  2011-10-24       Impact factor: 44.544

Review 7.  From the radiologic pathology archives: ewing sarcoma family of tumors: radiologic-pathologic correlation.

Authors:  Mark D Murphey; Lien T Senchak; Pramod K Mambalam; Chika I Logie; Mary K Klassen-Fischer; Mark J Kransdorf
Journal:  Radiographics       Date:  2013-05       Impact factor: 5.333

8.  Ewing's sarcoma: surgical resection as a prognostic factor.

Authors:  S L Sailer; D C Harmon; H J Mankin; J T Truman; H D Suit
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-07       Impact factor: 7.038

9.  The molecular biology of soft-tissue sarcomas and current trends in therapy.

Authors:  Jorge Quesada; Robert Amato
Journal:  Sarcoma       Date:  2012-05-10

10.  A single institution experience of combined modality management of extra skeletal Ewings sarcoma.

Authors:  Ramachandran Venkitaraman; Mathew K George; S Ganapathy Ramanan; T G Sagar
Journal:  World J Surg Oncol       Date:  2007-01-11       Impact factor: 2.754

View more
  11 in total

1.  Imaging Features of Primary Tumors and Metastatic Patterns of the Extraskeletal Ewing Sarcoma Family of Tumors in Adults: A 17-Year Experience at a Single Institution.

Authors:  Jimi Huh; Kyung Won Kim; Seong Joon Park; Hyoung Jung Kim; Jong Seok Lee; Hyun Kwon Ha; Sree Harsha Tirumani; Nikhil H Ramaiya
Journal:  Korean J Radiol       Date:  2015-07-01       Impact factor: 3.500

Review 2.  Current Concepts in Non-Gastrointestinal Stromal Tumor Soft Tissue Sarcomas: A Primer for Radiologists.

Authors:  Akshay D Baheti; Jyothi P Jagannathan; Ailbhe O'Neill; Harika Tirumani; Sree Harsha Tirumani
Journal:  Korean J Radiol       Date:  2017-01-05       Impact factor: 3.500

3.  Retroperitoneal Ewing's sarcoma/embryonal tumor: a rare differential diagnosis of back pain.

Authors:  Fabiano Reis; Eduardo Macedo; Marcondes Cavalcanti França Junior; Eliane Ingrid Amstalden; Simone Appenzeller
Journal:  Radiol Bras       Date:  2017 Nov-Dec

4.  Vaginal Ewing Sarcoma: An Uncommon Clinical Entity in Pediatric Patients.

Authors:  Nathan M Cross; A Luana Stanescu; Erin R Rudzinski; Douglas S Hawkins; Marguerite T Parisi
Journal:  J Clin Imaging Sci       Date:  2017-04-25

5.  Role of Radiation Therapy in Adult Extraskeletal Ewing's Sarcoma Patients Treated with Chemotherapy and Surgery.

Authors:  Augustine M Saiz; Alicia A Gingrich; Robert J Canter; Amanda R Kirane; Arta M Monjazeb; R Lor Randall; Steven W Thorpe
Journal:  Sarcoma       Date:  2019-04-24

6.  Case Report: Primary Ewing Sarcoma of the Penis With Multiple Metastases.

Authors:  Chuanxi Zheng; Yong Zhou; Yi Luo; Hongying Zhang; Chongqi Tu; Li Min
Journal:  Front Pediatr       Date:  2021-01-07       Impact factor: 3.418

7.  Ewing's Sarcoma of the Breast in a Young Woman: A Case Report and Review of the Literature.

Authors:  Simona Papi; Francesca Combi; Silvia Segattini; Silvia Accogli; Enza Palma; Anna Gambini; Alessia Andreotti; Gabriele Luppi; Giovanni Tazzioli
Journal:  Front Oncol       Date:  2022-07-12       Impact factor: 5.738

8.  Imaging features and clinical course of undifferentiated round cell sarcomas with CIC-DUX4 and BCOR-CCNB3 translocations.

Authors:  Emily J Brady; Meera Hameed; William D Tap; Sinchun Hwang
Journal:  Skeletal Radiol       Date:  2020-08-25       Impact factor: 2.199

9.  Primary vaginal Ewing sarcoma with uterine fibroid: A case report.

Authors:  Maolin Xu; Yulin Liu; Shue Zeng; Hongbin Wang; Gaolong Weng; Fang Li
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817

10.  Extraskeletal Ewing's sarcoma: outcomes and CT features of endoceliac lesions.

Authors:  Zeyang Chen; Yang Jiao; Zining Liu; Jiejin Yang; Jiali Sun; Pengyuan Wang
Journal:  Transl Cancer Res       Date:  2021-09       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.